Robert I. Shortman

1.2k total citations
24 papers, 633 citations indexed

About

Robert I. Shortman is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert I. Shortman has authored 24 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert I. Shortman's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Medical Imaging and Pathology Studies (5 papers). Robert I. Shortman is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Medical Imaging and Pathology Studies (5 papers). Robert I. Shortman collaborates with scholars based in United Kingdom, South Africa and United States. Robert I. Shortman's co-authors include Ashley M. Groves, Thida Win, Raymondo Endozo, Balaji Ganeshan, Irfan Kayani, Peter J. Ell, Kenneth A. Miles, Stephen P. Lowis, Simon Wan and Joanna C. Porter and has published in prestigious journals such as New England Journal of Medicine, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Robert I. Shortman

22 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert I. Shortman United Kingdom 14 314 270 129 104 55 24 633
Ben van den Borne Netherlands 11 349 1.1× 168 0.6× 36 0.3× 223 2.1× 17 0.3× 28 697
R. Jennelle United States 16 156 0.5× 121 0.4× 30 0.2× 151 1.5× 26 0.5× 52 648
Eduard L. Mooyaart Netherlands 12 923 2.9× 592 2.2× 190 1.5× 138 1.3× 24 0.4× 18 1.4k
H. Raat Netherlands 11 244 0.8× 160 0.6× 136 1.1× 30 0.3× 25 0.5× 19 569
Biu Chan Canada 10 129 0.4× 131 0.5× 108 0.8× 90 0.9× 11 0.2× 13 468
Norinari Honda Japan 12 176 0.6× 141 0.5× 62 0.5× 63 0.6× 17 0.3× 53 478
Véronique E. Mul Netherlands 17 373 1.2× 231 0.9× 55 0.4× 229 2.2× 45 0.8× 33 762
Hyun-ju Lim South Korea 12 296 0.9× 186 0.7× 25 0.2× 85 0.8× 35 0.6× 18 573
Christina Schröder Germany 14 161 0.5× 168 0.6× 29 0.2× 64 0.6× 18 0.3× 72 597
Patrick D. Maguire United States 14 439 1.4× 132 0.5× 218 1.7× 498 4.8× 147 2.7× 31 1.2k

Countries citing papers authored by Robert I. Shortman

Since Specialization
Citations

This map shows the geographic impact of Robert I. Shortman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Shortman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Shortman more than expected).

Fields of papers citing papers by Robert I. Shortman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Shortman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Shortman. The network helps show where Robert I. Shortman may publish in the future.

Co-authorship network of co-authors of Robert I. Shortman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Shortman. A scholar is included among the top collaborators of Robert I. Shortman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Shortman. Robert I. Shortman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Årstad, Erik, Kerstin Sander, Tom Kurzawinski, et al.. (2025). Adrenal Aldosterone Synthase Expression Imaging in Primary Aldosteronism. New England Journal of Medicine. 393(21). 2168–2170.
2.
Ganeshan, Balaji, Thida Win, Nicholas Screaton, et al.. (2025). [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease. Journal of Nuclear Medicine. 66(7). jnumed.125.269497–jnumed.125.269497. 1 indexed citations
3.
Ganeshan, Balaji, Simon Wan, Manuel Rodriguez‐Justo, et al.. (2025). Texture analysis of [18F]FDG PET/CT may stratify risk in stage II colorectal cancer – discovery findings. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1789–1802.
4.
5.
Thornton, Andrew, Francesco Fraioli, Simon Wan, et al.. (2021). Evolution of 18F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation. Journal of Nuclear Medicine. 63(2). 270–273. 9 indexed citations
7.
Fraioli, Francesco, Maria Lyasheva, Joanna C. Porter, et al.. (2019). Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF). European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2023–2031. 22 indexed citations
8.
Win, Thida, Nicholas Screaton, Joanna C. Porter, et al.. (2018). Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). European Journal of Nuclear Medicine and Molecular Imaging. 45(5). 806–815. 51 indexed citations
9.
Shortman, Robert I., et al.. (2017). Development of PET/CT and PET/MRI Patient-Information Videos in Collaboration with Patients Previously Treated for Cancer. Journal of Nuclear Medicine Technology. 46(1). 26–28. 1 indexed citations
10.
Ganeshan, Balaji, Kenneth A. Miles, Robert I. Shortman, et al.. (2016). CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas. European Radiology. 27(3). 1012–1020. 50 indexed citations
11.
Endozo, Raymond, Sofia Michopoulou, Robert I. Shortman, et al.. (2016). PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand. Journal of Nuclear Medicine. 58(5). 774–780. 28 indexed citations
12.
Shortman, Robert I., et al.. (2015). A comparison of the psychological burden of PET/MRI and PET/CT scans and association to initial state anxiety and previous imaging experiences. British Journal of Radiology. 88(1052). 20150121–20150121. 21 indexed citations
13.
Win, Thida, Kenneth A. Miles, Sam M. Janes, et al.. (2013). Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(13). 3591–3599. 167 indexed citations
14.
Win, Thida, Benjamin A. Thomas, Tryphon Lambrou, et al.. (2013). Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. European Journal of Nuclear Medicine and Molecular Imaging. 41(2). 337–342. 60 indexed citations
15.
Win, Thida, Nicholas Screaton, Joanna C. Porter, et al.. (2012). Novel Positron Emission Tomography/Computed Tomography of Diffuse Parenchymal Lung Disease Combining a Labeled Somatostatin Receptor Analogue and 2-Deoxy-2 [18F] Fluoro-D-Glucose. Molecular Imaging. 11(2). 91–8. 22 indexed citations
16.
Penn, Anthony, Stephen P. Lowis, Michaël C.G. Stevens, et al.. (2011). A Detailed Prospective Longitudinal Assessment of Health Status in Children With Brain Tumors in the First Year After Diagnosis. Journal of Pediatric Hematology/Oncology. 33(8). 592–599. 9 indexed citations
17.
Win, Thida, Tryphon Lambrou, Brian Hutton, et al.. (2011). 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. European Journal of Nuclear Medicine and Molecular Imaging. 39(3). 521–528. 37 indexed citations
18.
Penn, Anthony, Robert I. Shortman, Stephen P. Lowis, et al.. (2010). Child‐related determinants of health‐related quality of life in children with brain tumours 1 year after diagnosis. Pediatric Blood & Cancer. 55(7). 1377–1385. 23 indexed citations
19.
Penn, Anthony, Stephen P. Lowis, Michael C. Stevens, et al.. (2009). Family, demographic and illness‐related determinants of HRQL in children with brain tumours in the first year after diagnosis. Pediatric Blood & Cancer. 53(6). 1092–1099. 39 indexed citations
20.
Penn, Anthony, Stephen P. Lowis, Linda Hunt, et al.. (2007). Health related quality of life in the first year after diagnosis in children with brain tumours compared with matched healthy controls; a prospective longitudinal study. European Journal of Cancer. 44(9). 1243–1252. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026